NCT05758311

Brief Summary

It is essential to delve deeper into the molecular and tissue aspects that allow us to recognize the roles of adipose tissue and its interaction with the musculoskeletal (i.e., adipomyokines) to facilitate the identification of biomarkers that can complement the assessment of body composition. Thus, investigators posed the following research question: what characteristics of adipose tissue can investigators consider to rethink assessment for the diagnosis and treatment of obesity? The 'Project ATA' is a cross-sectional study based on the Strengthening the Reporting of Observational Studies in Epidemiology-Nutritional Epidemiology (STROBE-nut) guidelines, an Extension of the STROBE Statement. The FINER strategy (Feasible, Interesting, Novel, Ethical, and Relevant) and previously published guidelines for organizing a multicenter study will be followed. The 'Project ATA' will test the associations of several morphological metrics and adipomyokines in order to both profile populations with excess body fat and to establish practical geographical-based recommendations for practitioners.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
378

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 6, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

March 7, 2023

Completed
10 months until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

September 7, 2023

Status Verified

September 1, 2023

Enrollment Period

5 months

First QC Date

February 6, 2023

Last Update Submit

September 5, 2023

Conditions

Keywords

Body CompositionBody Fat DistributionBiomarkersCardiovascular RiskAnthropometryBioelectrical ImpedanceAdipomyokines

Outcome Measures

Primary Outcomes (4)

  • Anthropometric Assessment

    All measurements will be performed according to the International Standards for Anthropometric Evaluation published by the International Society for the Advancement of Kineanthropometry (ISAK) to obtain basic measurements expressed in absolute data. Means will be calculated and analyzed from two measurements of anthropometric data.

    July 2023 to August 2024

  • Anthropometry-Based Analysis of Body Composition

    The whole-body fat percentage (RFM), the sum of skinfolds, the waist girth (minimal and umbilicus), the body mass to waist girth, waist girth to stature ratios. Finally, musculoskeletal index, the skinfold-corrected muscle girths for the arm, chest, waist, thigh, and calf will be calculated according to the expression: girth - (π x skinfold).

    July 2023 to August 2024

  • Bioelectrical Impedance Analysis

    To evaluate adult subjects with excess adiposity by foot-to-foot bioelectrical impedance analysis (BIA). Estimated values of percent fat mass (FM), percent muscle mass (MA), metabolic age (ma), basal metabolic rate (BMR), and visceral fat (VFL). In addition, bioelectrical impedance vector analysis (BIVA) will be performed and raw variables related to phase angle and body composition will be reported.

    July 2023 to August 2024

  • Adipokines and blood screening

    Will be collected peripheral blood samples, where it will be taken into account serum amyloid A, resistin, leptin, adiponectin, and visfatin concentrations will be quantified by direct chemiluminescence using acridinium ester technology.

    July 2023 to August 2024

Study Arms (1)

Multi-center study

The study population will be inhabitants of both sexes with different levels of physical activity who reside in the metropolitan area of cities in Colombia, Mexico, Costa Rica, and Spain. The population sample will be obtained through an internal call to students and administrative personnel of universities and Smart Fit sites with an inter-institutional collaboration agreement with Dynamical Business \& Science Society (DBSS International). The first study will be carried out in Colombia.

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population will be inhabitants of both sexes with different levels of physical activity who reside in the metropolitan area of cities in Colombia, Mexico, Costa Rica, and Spain. Investigators will primarily consider university students, administrative personnel, and other potentially eligible adults of both sexes who respond to the study announcement, fulfill inclusion criteria and sign the informed consent form. To understand the prevalence or proportion of a given phenotype among adults in a city a formula based on previously reported proportions will be used to calculate the sample size.

You may qualify if:

  • People over 18 years of age (under 60 years of age).
  • People born and residing in major cities or neighboring municipalities of the metropolitan area of selected cities. The first stage will take place in Medellín (Colombia) and then continue in other cities in Colombia, Costa Rica, Mexico, and Spain according to logistics procedures.
  • Those who sign the informed consent to undergo the measurements.

You may not qualify if:

  • Those physically active people who exercise vigorously and systematically or at a competitive level.
  • Those diagnosed with a musculoskeletal disease and/or special condition that limits mobility during the taking of measurements (musculoskeletal injury).
  • People over 60 years of age.
  • Pregnant women.
  • People with implants or synthetic prostheses.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

DBSS

Bogotá, 110311, Colombia

Location

Related Publications (3)

  • Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016 Jun;22(7 Suppl):s176-85.

    PMID: 27356115BACKGROUND
  • Bonilla DA, De Leon LG, Alexander-Cortez P, Odriozola-Martinez A, Herrera-Amante CA, Vargas-Molina S, Petro JL. Simple anthropometry-based calculations to monitor body composition in athletes: Scoping review and reference values. Nutr Health. 2022 Mar;28(1):95-109. doi: 10.1177/02601060211002941. Epub 2021 Apr 1.

    PMID: 33792415BACKGROUND
  • Bremner JD, Moazzami K, Wittbrodt MT, Nye JA, Lima BB, Gillespie CF, Rapaport MH, Pearce BD, Shah AJ, Vaccarino V. Diet, Stress and Mental Health. Nutrients. 2020 Aug 13;12(8):2428. doi: 10.3390/nu12082428.

    PMID: 32823562BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Peripheral blood samples will be collected from the forearm veins of the participants to quantify the concentration of adipokines and lipid profile.

MeSH Terms

Conditions

Sedentary BehaviorOverweightObesity

Condition Hierarchy (Ancestors)

BehaviorOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Diego A Bonilla, MSc

    Research Division, Dynamical Business & Science Society - DBSS International SAS, Bogotá, Colombia

    PRINCIPAL INVESTIGATOR
  • Luis M Gómez-Miranda, PhD

    Sports School, Autonomous University of Baja California, Tijuana 22390, México

    PRINCIPAL INVESTIGATOR
  • Daniel Rojas-Valverde, PhD

    Núcleo de Estudios para el Alto Rendimiento y la Salud (CIDISAD-NARS), Heredia, Costa Rica

    PRINCIPAL INVESTIGATOR
  • Salvador Vargas-Molina, MSc

    Faculty of Sport Sciences, EADE-University of Wales Trinity Saint David, 29018 Málaga, Spain

    PRINCIPAL INVESTIGATOR
  • Katherine Franco-Hoyos, MSc

    Nutral, Universidad CES, Medellín, Colombia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Diego A Bonilla, MSc

CONTACT

Jorge L Petro, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2023

First Posted

March 7, 2023

Study Start

January 1, 2024

Primary Completion

June 1, 2024

Study Completion

December 1, 2024

Last Updated

September 7, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

The data collected in this study will be used for research purposes, according to the bioethical standards established by the Institutional Review Board (IRB) and the procedures will be developed in accordance with the latest version of the Declaration of Helsinki. Investigators will not share the identity of those who participate in the research. The information investigators collect in this research project will be kept confidential, will be kept off-limits, and no one except the researchers will have access to it. Any information about the participant will have an identifying number (rather than the name) at the time of analysis. Only the researchers will know what the number is and the information will be kept confidential. It will not be shared or given to anyone except participants, a Data and Safety Monitoring Board (DSMB), or others participants authorize (e.g., physician, nutritionist).

Locations